These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34419749)

  • 1. Generation of a COL4A5 heterozygous mutation human embryonic stem cell line (WAe009-A-58) using an episomal vector-based CRISPR/Cas9 system.
    Tian L; Wu F; Bai R; Ma S; Zheng H; Liu WJ; Wang Y
    Stem Cell Res; 2021 Aug; 55():102481. PubMed ID: 34419749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X-linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene.
    Sun L; Zhang J; Kuang XY; Kang YL; Wu Y; Huang WY
    Stem Cell Res; 2020 May; 45():101833. PubMed ID: 32416580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating dHAND homozygous knockout human embryonic stem cell line (WAe009-A-59) by episomal vector-based CRISPR/Cas9 system.
    Wang W; Bai R; Song X
    Stem Cell Res; 2021 Aug; 55():102471. PubMed ID: 34332328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of an induced pluripotent stem cell line from a patient with X-linked Alport syndrome carrying a hemizygous splicing variant (NM_033380; c.929[exon 16]delG) in the collagen type IV alpha 5 chain gene.
    Zhang D; Li K; Yang X; Wang H; Yu X
    Stem Cell Res; 2024 Oct; 80():103488. PubMed ID: 39053318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system.
    Wu F; Li X; Bai R; Li Y; Gao J; Lan F
    Stem Cell Res; 2020 Oct; 48():101930. PubMed ID: 32777767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome.
    Aoto Y; Kise T; Nakanishi K; Nagano C; Horinouchi T; Yamamura T; Ishiko S; Sakakibara N; Shima Y; Morisada N; Iijima K; Nozu K
    CEN Case Rep; 2020 Nov; 9(4):431-436. PubMed ID: 32621070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an iPSC line (GWCMCi002-A) from an X-linked Alport syndrome patient with a hemizygous splicing mutation (NM_000495.4, c. 1517-1 G > T) in the COL4A5 gene.
    Gao X; Li G; Deng H; Feng W; Li Y; Liu M; Li Y
    Stem Cell Res; 2021 May; 53():102388. PubMed ID: 34088015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
    Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
    Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a FLNA knockout hESC line (WAe009-A-P) to model cardiac valvular dysplasia using CRISPR/Cas9.
    Lu F; Gao Y; Li E
    Stem Cell Res; 2023 Sep; 71():103162. PubMed ID: 37429070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a human TLR4 compound heterozygous knockout hESC line (WAe009-A-N) to model toll-like receptor 4 deficiency by CRISPR/Cas9 system.
    Ruan Y; Tian X; Li X; Zhang Y
    Stem Cell Res; 2023 Dec; 73():103225. PubMed ID: 37931537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CRISPR/Cas9 strategy for the generation of a FLNC knockout hESC line (WAe009-A-70) to model dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy.
    Qin Z; Sun L; Sun X; Su H; Gao X
    Stem Cell Res; 2021 Oct; 56():102562. PubMed ID: 34634758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a TLR7 heterozygous knockout line (WAe009-A-18) from human embryonic stem cells using CRISPR/Cas9.
    Seo HH; Han HW; Kim JH
    Stem Cell Res; 2020 May; 45():101735. PubMed ID: 32268246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
    Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
    Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of two induced pluripotent stem cell lines from patients with X-linked Alport syndrome.
    Ma Y; Wang Z; Gao M; Liu X; Sun W; Gong Y; Sun G; Liu G
    Stem Cell Res; 2021 May; 53():102343. PubMed ID: 33878711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Alport syndrome COL4A5 variant database.
    Crockett DK; Pont-Kingdon G; Gedge F; Sumner K; Seamons R; Lyon E
    Hum Mutat; 2010 Aug; 31(8):E1652-7. PubMed ID: 20574986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples.
    Tazón-Vega B; Ars E; Burset M; Santín S; Ruíz P; Fernández-Llama P; Ballarín J; Torra R
    Am J Kidney Dis; 2007 Aug; 50(2):257.e1-14. PubMed ID: 17660027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female X-linked Alport syndrome with somatic mosaicism.
    Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
    Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 families.
    Nabais Sá MJ; Sampaio S; Oliveira A; Alves S; Moura CP; Silva SE; Castro R; Araújo JA; Rodrigues M; Neves F; Seabra J; Soares C; Gaspar MA; Tavares I; Freitas L; Sousa TC; Henriques AC; Costa FT; Morgado E; Sousa FT; Sousa JP; da Costa AG; Filipe R; Garrido J; Montalban J; Ponce P; Alves R; Faria B; Carvalho MF; Pestana M; Carvalho F; Oliveira JP
    Clin Genet; 2015 Nov; 88(5):462-7. PubMed ID: 25307721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.